Previous Close | $17.06 |
Intrinsic Value | $3.75 |
Upside potential | -78% |
Data is not available at this time.
Community Healthcare Trust Incorporated (CHCT) is a real estate investment trust (REIT) specializing in healthcare-related properties, primarily serving outpatient medical facilities across the U.S. The company generates revenue through long-term triple-net leases, ensuring stable cash flows with built-in rent escalations. Its portfolio includes medical office buildings, specialty clinics, and other healthcare facilities, catering to the growing demand for decentralized healthcare services. CHCT focuses on secondary and tertiary markets, where it benefits from lower competition and higher barriers to entry, positioning itself as a niche player in the healthcare real estate sector. The company’s strategy emphasizes tenant diversification and property quality, mitigating risks associated with single-tenant dependencies. By aligning with demographic trends like aging populations and increased outpatient care, CHCT maintains a resilient market position despite broader economic fluctuations.
In FY 2024, CHCT reported revenue of $115.8 million, reflecting its steady lease-based income stream. However, the company posted a net loss of $3.2 million, with diluted EPS at -$0.23, indicating challenges in profitability. Operating cash flow stood at $58.9 million, demonstrating strong cash generation from core operations. Notably, capital expenditures were minimal, underscoring the REIT’s asset-light model and focus on existing property performance.
CHCT’s earnings power is underpinned by its triple-net lease structure, which transfers most property expenses to tenants. The negative net income suggests one-time costs or impairments, as operating cash flow remains robust. The company’s capital efficiency is evident in its ability to generate significant cash flow without substantial reinvestment, though leverage and interest expenses may weigh on net earnings.
CHCT’s balance sheet shows $4.4 million in cash and equivalents against $490 million in total debt, indicating a leveraged position. The absence of capital expenditures suggests disciplined capital allocation. While the debt load is substantial, the stability of healthcare-related rental income provides a cushion for debt servicing, though investors should monitor leverage ratios closely.
Growth is likely driven by strategic acquisitions and organic rent escalations, though FY 2024’s net loss may signal short-term headwinds. The company maintains a dividend of $1.95 per share, reflecting a commitment to shareholder returns despite earnings volatility. The payout ratio should be evaluated against cash flow sustainability given the current profitability challenges.
Market expectations for CHCT appear tempered, with negative earnings impacting valuation metrics. Investors may focus on the REIT’s cash flow stability and dividend yield, though leverage and profitability concerns could weigh on multiples. The stock’s performance will hinge on its ability to stabilize earnings and manage debt while capitalizing on healthcare real estate demand.
CHCT’s strategic advantages lie in its niche focus on healthcare properties and triple-net lease model, which provide predictable income. The outlook depends on its ability to navigate interest rate environments and expand its portfolio prudently. Demographic trends support long-term demand, but execution on profitability and debt management will be critical to sustaining investor confidence.
Company filings (10-K), investor presentations
show cash flow forecast
Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
Revenue growth rate, % | NaN | |||||||||||||||||||||||||
Revenue, $ | NaN | |||||||||||||||||||||||||
Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
Total operating expenses, $m | NaN | |||||||||||||||||||||||||
Operating income, $m | NaN | |||||||||||||||||||||||||
EBITDA, $m | NaN | |||||||||||||||||||||||||
Interest expense (income), $m | NaN | |||||||||||||||||||||||||
Earnings before tax, $m | NaN | |||||||||||||||||||||||||
Tax expense, $m | NaN | |||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
Total assets, $m | NaN | |||||||||||||||||||||||||
Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
Average production assets, $m | NaN | |||||||||||||||||||||||||
Working capital, $m | NaN | |||||||||||||||||||||||||
Total debt, $m | NaN | |||||||||||||||||||||||||
Total liabilities, $m | NaN | |||||||||||||||||||||||||
Total equity, $m | NaN | |||||||||||||||||||||||||
Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
Funds from operations, $m | NaN | |||||||||||||||||||||||||
Change in working capital, $m | NaN | |||||||||||||||||||||||||
Cash from operations, $m | NaN | |||||||||||||||||||||||||
Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
New CAPEX, $m | NaN | |||||||||||||||||||||||||
Total CAPEX, $m | NaN | |||||||||||||||||||||||||
Free cash flow, $m | NaN | |||||||||||||||||||||||||
Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
Discount rate, % | NaN | |||||||||||||||||||||||||
PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
Current shareholders' claim on cash, % | NaN |